Lara Zafrani, Grigoris Gerotziafas, Colleen Byrnes, Xuzhen Hu, Joelle Perez, Charlène Lévi, Sandrine Placier, Emmanuel Letavernier, Asada Leelahavanichkul, Jean-philippe Haymann, Ismail Elalamy, Jeffrey L. Miller, Robert A. Star, Peter S. T. Yuen and Laurent Baud Am. J. Respir. Crit. Care Med. April 1, 2012 vol. 185 no. 7 744-755
Abstract
Rationale: Sepsis, a leading cause of death worldwide, involves widespread activation of inflammation, massive activation of coagulation, and lymphocyte apoptosis. Calpains, calcium-activated cysteine proteases, have been shown to increase inflammatory reactions and lymphocyte apoptosis. Moreover, calpain plays an essential role in microparticle release.
Objectives: We investigated the contribution of calpain in eliciting tissue damage during sepsis.
Methods: To test our hypothesis, we induced polymicrobial sepsis by cecal ligation and puncture in wild-type (WT) mice and transgenic mice expressing high levels of calpastatin, a calpain-specific inhibitor.
Measurements and Main Results: In WT mice, calpain activity increased transiently peaking at 6 hours after cecal ligation and puncture surgery. Calpastatin overexpression improved survival, organ dysfunction (including lung, kidney, and liver damage), and lymphocyte apoptosis. It decreased the sepsis-induced systemic proinflammatory response and disseminated intravascular coagulation, by reducing the number of procoagulant circulating microparticles and therefore delaying thrombin generation. The deleterious effect of microparticles in this model was confirmed by transferring microparticles from septic WT to septic transgenic mice, worsening their survival and coagulopathy.
Conclusions: These results demonstrate an important role of the calpain/calpastatin system in coagulation/inflammation pathways during sepsis, because calpain inhibition is associated with less severe disseminated intravascular coagulation and better overall outcomes in sepsis.
Weblink here